Show results for
Refine by
Genomics Redefines The Boundaries Of Fungal Genomics Software In Europe
36 software items found
by:Qlucore AB based inLund, SWEDEN
Visualization is central in making it easy to understand data. By combining instant visualization with powerful statistics and flexible selection methods, you will be able to see your results ...
Manufactured by:Alithea Genomics based inEpalinges, SWITZERLAND
Demultiplexing, alignment and gene counts at the click of a ...
by:Qlucore AB based inLund, SWEDEN
Instant exploration is one of the key features in Qlucore Omics Explorer. As a user, you decide your own workflow and starting point. You are in control and can tailor the exploration to meet your specific ...
by:Qlucore AB based inLund, SWEDEN
Qlucore supports a wide variety of data and file formats, see list below. Great flexibility is provided with the Import ...
by:Portable Medical Technology Ltd. based inKillarney, IRELAND
ONCOassist is the go-to app for oncology and haematology professionals. It offers easy access to relevant, up-to-date tools and content when and where it is needed. With the advent of genomic sequencing, combined with an aging population, and new therapies. The decision-making process for oncology/haematology HCP’s is becoming increasingly complex. Unfortunately, there is not always easy ...
by:Lifebit based inHackney, UNITED KINGDOM
It’s challenging to make biomedical data both secure and usable. Lifebit CloudOS brings researcher’s analysis and computation to where the data resides, while enabling them to link other data sources virtually. This translates to faster insights from your data, accelerating patient ...
by:TriNetX, LLC based inCambridge, MASSACHUSETTS (USA)
The full set of base analytics are enabled on every network, except for anonymous networks such as Linked, where HCO attribution is not shown. With Explore Cohort, review the prevalence of diagnoses, treatments, and procedures among your cohort, retrieve lab value means and standard deviations, and count instances of variants by genome. Use Criteria Analysis to rank order your query ...
by:BC Platforms based inZürich, SWITZERLAND
BC|RQUEST as a private service enables availability queries and aggregated analysis on biobanks or internal data silos through a simple web interface for query building and analysis creation. Additionally, BC|RQUEST gives biobanks tools to manage their research project portfolio and research user capability to request and follow projects through integrated ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Next-generation sequencing (NGS) of the human exome has the potential to identify pathogenic variants responsible for complex phenotypes associated with rare ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Metabolic disorders are a major cause of morbidity and mortality, representing a growing health concern worldwide. Over the last decade, substantial progress has been made in the discovery of genetic variants influencing a range of metabolic diseases.1 The advances in next generation sequencing (NGS) technologies have contributed to elucidation of the pathogenic role of variants associated with ...
by:Quretec Ltd based inTartu, ESTONIA
Quretec has made Estonian 2011 census data collection solution, holding world record with 66% of country population participated in the e-census. Qure Data Management Platform is a web-based database software, that can be used for collection, handling, and analysis of data under high quality, security, and robustness requirements. Qure Data Management platform is well suitable for diagnosis or ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Next-generation sequencing (NGS) has the potential to revolutionize the diagnosis and treatment of cancers and rare diseases but creates extremely large, complex, and noisy datasets for analysis. Without the right analytical technology, pinpointing causative variants and obtaining actionable insights from NGS data requires specialist skills, multiple resources, and considerable time. The ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Cardiac diseases are the #1 cause of death globally1,2. Genetic testing is frequently considered a key component of the clinical management process of inherited cardiac disorders, such as hypertrophic, dilated, and arrhythmogenic cardiomyopathies, aortopathies, and inherited arrhythmia syndromes3. This approach is typically reserved for patients with a confirmed or suspected diagnosis of an ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Alamut Visual Plus™ enables deep assessment of variants on a genomic scale, empowering clinical researchers to make accurate decisions for their data interpretation. Alamut Visual Plus™ is a full genome browser designed to help researchers investigate variations of the human genome. The software combines a wide set of external data with high-quality missense and splicing predictors in ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Clinical interpretation has been one of the most complex and time-consuming aspects of transforming genomic data into meaningful results, until ...
by:Qlucore AB based inLund, SWEDEN
The combination of powerful statistics and instant visualization drives exciting results. Flexibility and expansion are cornerstones. Analyze data using an easy to use statistical model. Integrate and extend the analysis with Python based Templates for scripting. Add statistical methods through the Open API to R. Filter on genomic entities such as read coverage and variants with the NGS module. ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Maximize your biologically actionable insights from small tumor samples with the SOPHiA DDM™ RNAtarget Technology end-to-end solutions. Gene fusions have been associated with various tumors and are recognized as valuable cancer biomarkers in cancer research1. Targeted RNA sequencing is recommended to maximize novel fusion detection by identifying transcribed and potentially actionable ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Hematological tumors represent the fourth most frequent cancer type in the developed world. In addition to the continuously evolving clinical guidelines2, harnessing of all the available information when investigating hematological disorders into meaningful insights can be outdated, inaccurate, costly, and time-consuming. This ultimately risks limiting researchers’ productivity, thus ...
by:TriNetX, LLC based inCambridge, MASSACHUSETTS (USA)
Data sourced from the EHRs of U.S. healthcare organizations forms the foundation of this combined data asset, providing a rich clinical picture of patients from encounters with providers, lab results, procedures, medication orders, and genomics. Medical and pharmacy claims provide insight into a patient’s care before and after these encounters, regardless of provider. Pre-existing ...
by:BC Platforms based inZürich, SWITZERLAND
BC | INSIGHT is a data and research management solution for clinical genomics studies. Genomic and phenotypic data is collected and stored on the platform, and users have access to data and tools through an application account. All common data types for NGS, GWAS, variant analysis, linkage, and other statistics can be managed on the platform. BC|INSIGHT scales up from small candidate gene studies ...